Metformin use and cervical cancer risk in female patients with type 2 diabetes
about
Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer.Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus.Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes.Metformin and lung cancer risk in patients with type 2 diabetes mellitus.Sitagliptin and oral cancer risk in type 2 diabetes patients.
P2860
Q36194195-923E8A9C-F80A-4D8B-B110-462B06B7FAC7Q37274957-28C98164-531A-4C14-9C80-E82C0D537286Q37709423-F7F54FCC-5231-491B-A80B-2326EC9576E0Q37745840-16A65CA4-DDAA-4F9C-B86E-C7DFD5984DDCQ37745926-8B271984-A0D9-48E6-8543-D0C53E6AF7D0Q41092838-832BEA53-FD96-4A9A-9A33-AB7AE09B2899Q47096984-459B7BE5-6F62-4C26-B3D1-F70F0D5B50A2
P2860
Metformin use and cervical cancer risk in female patients with type 2 diabetes
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metformin use and cervical cancer risk in female patients with type 2 diabetes
@en
Metformin use and cervical cancer risk in female patients with type 2 diabetes.
@nl
type
label
Metformin use and cervical cancer risk in female patients with type 2 diabetes
@en
Metformin use and cervical cancer risk in female patients with type 2 diabetes.
@nl
prefLabel
Metformin use and cervical cancer risk in female patients with type 2 diabetes
@en
Metformin use and cervical cancer risk in female patients with type 2 diabetes.
@nl
P2860
P356
P1433
P1476
Metformin use and cervical cancer risk in female patients with type 2 diabetes
@en
P2093
Chin-Hsiao Tseng
P2860
P304
59548-59555
P356
10.18632/ONCOTARGET.10934
P407
P577
2016-07-29T00:00:00Z